|
Article Excerpt
PITTSBURGH, Jan. 9 /PRNewswire/ -- Cellomics, Inc., the world's first and leading producer of tools for High Content Screening (HCS), announced today a $5.3 million round of financing. The list of investors includes Carl Zeiss MicroImaging, Inc., Oxford Bioscience Partners, Vector Fund Management, InterWest Partners, Alta California Partners, Burrill Biotechnology, Axiom Venture Partners, and CK Capital.
(Logo: http://www.newscom.com/cgi-bin/prnh/20010611/PHM032LOGO )
In 2003, Cellomics collaborated with Carl Zeiss to design, engineer and manufacture the ArrayScan(R) VTI which was launched in the fourth quarter. Carl Zeiss MicroImaging, Inc. is also a distributor and service partner of Cellomics for the North American academic and...
|
|
More articles from PR Newswire
Succession Planning Mistakes: 29% of Companies See No Need for Structu..., January 09, 2004
Business in Asia Today -- Jan. 9, 2004., January 09, 2004
Asian Markets -- Shares End Higher -- Jan. 9., January 09, 2004
IntraLuminal Safe-Cross(TM) Total Occlusion Crossing System Receives 5..., January 09, 2004
Speedel Completes Its 2003 Mezzanine Financing By Raising Additional C..., January 09, 2004
Looking for additional articles?
Search our database of over 3 million articles.
Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication
name or publication date.
About Goliath
Whether you're looking for sales prospects, competitive information, company
analysis or best practices in managing your organization,
Goliath can help you meet your business needs.
Our extensive business information databases empower business
professionals with both the breadth and depth of credible,
authoritative information they need to support their business
goals. Whether it be strategic planning, sales prospecting,
company research or defining management best practices -
Goliath is your leading source for accurate information.
|
|
